[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342851-105":59,"doc-detail-342851-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-health-state-of-france-before-covid-19-pandemic-between-1990-and-2019-an-analysis-of-the-global-burden-of-disease-study-2019","The health state of France before COVID-19 pandemic between 1990 and 2019 - an analysis of the Global Burden of Disease study 2019","","Assesses the burden of diseases in France before COVID-19 using Global Burden of Disease (GBD) metrics for 1990–2019 and compares French age-standardized indicators with Western European countries. Employs SDI, life expectancy (LE), healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) with 95% uncertainty intervals. Results show rising LE and HALE, falling DALYs per 100,000, and differential disease-specific drivers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-health-state-of-france-before-covid-19-pandemic-between-1990-and-2019-an-analysis-of-the-global-burden-of-disease-study-2019/342851/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-health-state-of-france-before-covid-19-pandemic-between-1990-and-2019-an-analysis-of-the-global-burden-of-disease-study-2019/342851.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and metrics are used to analyze France’s disease burden?","Question",{"text":112,"@type":113},"The study uses Global Burden of Diseases (GBD) metrics including SDI, life expectancy (LE), healthy life expectancy (HALE), YLLs, YLDs, and DALYs, with 95% uncertainty intervals.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did life expectancy and healthy life expectancy in France change from 1990 to 2019?",{"text":117,"@type":113},"Life expectancy at birth increased from 77.2 years in 1990 to 82.9 years in 2019. HALE at birth rose from 67.0 to 71.5 over the same period.",{"name":119,"@type":110,"acceptedAnswer":120},"Which causes contributed most to YLLs and YLDs in France?",{"text":121,"@type":113},"Neoplasms and cardiovascular diseases were the two leading causes of YLLs. Mental and musculoskeletal disorders were the two leading causes of YLDs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342851,1790131019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Articles   \nThe health state of France before COVID-19pandemic between 1990 and 2019: an analysis of the Global Burden of Disease study 2019  \nFlorence Francis-Oliviero,a,b,c,∗ Panayotis Constantinou,d Romana Haneef,e French GBD Collaborators, Michal Schwarzinger,b,f Anne Gallay,e Antoine Rachas,d and François Allab,c,f  \naService d’information médicale, Bordeaux University Hospital, 33000 Bordeaux, France bInserm UMR 1219-Bordeaux Population Health, 33000 Bordeaux, France  \ncUniversity of Bordeaux, 33000 Bordeaux, France  \ndDirection de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, 75 986 Paris Cedex 20, France eDepartment of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France  \nfDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, 33000 Bordeaux, France  \nSummary  \nBackground France faces nowadays some major challenges regarding its health care system including medically underserved areas, social health inequalities, and hospital pressures. Various indicators and sources of data allow us to describe the health status ofa population and, consequently, to assess the impact of these challenges. We assessed the burden of diseases before COVID-19 in France in 2019 and its evolution from 1990 to 2019, and compared it with Western European countries.  \nMethods We used speciﬁc Global Burden of Diseases (GBD) metrics: socio-demographic index (SDI), life expectancy (LE), healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) with their 95% uncertainty interval (95% UI) . We compared French age-standardized metrics to those for other Western European Countries for both sexes and also between 1990 and 2019 . We also described the speciﬁc causes of these different metrics.  \nFindings We observed for life expectancy at birth in France a trend to an improvement over time from 77.2 (95% UI: 77.2–77.3) years in 1990 to 82.9 (82.7–83.1) in 2019, which represented the seventh highest life expectancy among 23 Western European countries. HALE at birth in France increased from 67.0 (64.0–69.7) to 71.5 (68.1–74.5), which represented the fourth highest HALE among 23 Western European countries. In France, the total number of DALY per 100.000 population tended to decrease from 25,192 (22,374–28,351) in 1990 to 18,782 (16,408–21,920) in 2019 . As compared to other European countries, the burden due to cardiovascular diseases was lower. Neoplasms and cardiovascular diseases were the two leading causes of YLLs. Mental and musculoskeletal disorders were the two leading causes of YLDs.  \nInterpretation Overall, these results highlight a clear trend of improvement in the health status in France with certain differences between western European countries. The health policy makers need to devise interventional strategies to reduce the burden of diseases and injuries, with speciﬁc attention to causes such as cancers, cardiovascular diseases, mental health and musculoskeletal disorders.  \nFunding Bill & Melinda Gates Foundation.  \nCopyright © 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nKeywords: “Global Burden of disease” evolution; France; Western Europe  \nIntroduction  \nFrench health care system stands out in Europe, due to some speciﬁcities. It is a combination of Bismarckian and Beveridgian models, which lies on a national system  \nof health insurance funded by employee and employer social contributions.2 Indeed, French healthcare system combined a universal health coverage provided by the“Sécurité sociale” a national health insurance, which  \n*Corresponding author.  \nE-mail address: ﬂorence.francis@u-bordeaux.fr (F. Francis-Oliviero) .  \nThe Lancet Regional Health - Europe 2024;39: 100848  \nPublished Onli","cbCaichX8VMQ63Ur","https://ap.wps.com/l/cbCaichX8VMQ63Ur","pdf",4362386,13,"English","# Summary\n## Background\n## Methods\n## Findings\n## Interpretation\n## Funding\n# Research in context\n## Evidence before this study","[{\"question\":\"What data and metrics are used to analyze France’s disease burden?\",\"answer\":\"The study uses Global Burden of Diseases (GBD) metrics including SDI, life expectancy (LE), healthy life expectancy (HALE), YLLs, YLDs, and DALYs, with 95% uncertainty intervals.\"},{\"question\":\"How did life expectancy and healthy life expectancy in France change from 1990 to 2019?\",\"answer\":\"Life expectancy at birth increased from 77.2 years in 1990 to 82.9 years in 2019. HALE at birth rose from 67.0 to 71.5 over the same period.\"},{\"question\":\"Which causes contributed most to YLLs and YLDs in France?\",\"answer\":\"Neoplasms and cardiovascular diseases were the two leading causes of YLLs. Mental and musculoskeletal disorders were the two leading causes of YLDs.\"}]","The health state of France before COVID-19 pandemic between 1990 and 2019 - an analysis of the Global Burden of Disease study 2019 | PDF",1790048403,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2aa9a3c717791e7c4e19cf4ffa0ed8fd.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcda3b2f38b53b82a9ca9473dab36b59.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bda2789a958de754f3622b2d94f1d15.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a6be18fed6c37b4d9becfe67465e429.webp",980,1306]